Table 3 Characteristics of complications in the 37 patients who developed NRH.
| Variable | Frequency |
|---|---|
| Circumstances leading to the discovery of NRH (n (%)) | |
| Clinicals symptoms of portal hypertension | 12 (32) |
| Imaging of portal hypertension | 4 (11) |
| Biological abnormalities: hepato‐ and/or haemotoxicity* | 21 (57) |
| Liver biopsies | |
| Confirmed cases of NRH (n (%)) | 29 (78) |
| Suspected cases of NRH (n (%)) | 8 (22) |
| Laboratory variables at diagnosis of NRH (n (%)) | |
| No biological anomalies | 2 (5) |
| Liver abnormalities* | 5 (14) |
| Thrombocytopenia* | 4 (11) |
| Both* | 26 (70) |
| Portal hypertension at diagnosis (endoscopy and/or liver imaging) (n (%)) | 31 (84) |
*Raised alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, or bilirubin to >1.2 times the upper limit of normal range; platelets <150×109/l.
NRH, nodular regenerative hyperplasia.